Raquel Sanches-Kuiper, Vice President of Science and Applications at Evonetix, and Clare Whitewoods, Marketing Communications Manager at Evonetix, look at the benefits synthetic DNA brings to pharmaceutical development. Engineering biology is reshaping the world, from enabling the rapid development of vaccines to providing alternatives to petroleum fuels. The rapid progress made over the past two […]
To read this content in full, you need to login.
Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!